Capital Research Global Investors Takeda Pharmaceutical CO LTD Transaction History
Capital Research Global Investors
- $440 Billion
- Q1 2025
A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,201,004 shares of TAK stock, worth $192 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,201,004
Previous 13,162,513
0.29%
Holding current value
$192 Million
Previous $174 Million
12.64%
% of portfolio
0.04%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding TAK
# of Institutions
360Shares Held
67.4MCall Options Held
1.72MPut Options Held
186K-
Morgan Stanley New York, NY5.7MShares$83.1 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$77.5 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$51.1 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$50 Million0.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.16MShares$46 Million0.08% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.3B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...